Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

Urothelial carcinoma (UC) is a frequent cause of cancer-related deaths worldwide. Metastatic UC has been historically associated with poor prognosis, with a median overall survival of approximately 15 months and a 5-year survival rate of 18%. Although platinum-based chemotherapy remains the mainstay...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollica, Veronica, Rizzo, Alessandro, Montironi, Rodolfo, Cheng, Liang, Giunchi, Francesca, Schiavina, Riccardo, Santoni, Matteo, Fiorentino, Michelangelo, Lopez-Beltran, Antonio, Brunocilla, Eugenio, Brandi, Giovanni, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352972/
https://www.ncbi.nlm.nih.gov/pubmed/32498352
http://dx.doi.org/10.3390/cancers12061449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352972/
https://www.ncbi.nlm.nih.gov/pubmed/32498352
http://dx.doi.org/10.3390/cancers12061449

Ejemplares similares